FDA approves Merck’s Keytruda in combination with chemotherapy for advanced lung cancer treatment

pharmanewsdaily- May 14, 2017 0

The US Food and Drug Administration (FDA) has granted approval to Merck’s cancer immunotherapy, Keytruda (pembrolizumab), in combination with chemotherapy, as a first-line treatment option ... Read More

FDA approves Genentech’s lucentis for comprehensive diabetic retinopathy treatment

pharmanewsdaily- April 23, 2017 0

Genentech, a member of the Roche Group, has received approval from the U.S. Food and Drug Administration (FDA) for its lucentis (ranibizumab injection), making it ... Read More

FDA approves Neurocrine Biosciences’ Ingrezza for tardive dyskinesia

pharmanewsdaily- April 15, 2017 0

Neurocrine Biosciences has achieved a major milestone with the U.S. Food and Drug Administration (FDA) approving its medication, Ingrezza (valbenazine) capsules, for the treatment of ... Read More

FDA approves Genentech’s Ocrevus for multiple sclerosis treatment

pharmanewsdaily- April 2, 2017 0

In a landmark decision, the US Food and Drug Administration (FDA) has granted approval to Genentech, a subsidiary of the Roche Group, for its multiple ... Read More

Sanofi and Regeneron’s Dupixent receives FDA approval for atopic dermatitis treatment

pharmanewsdaily- April 2, 2017 0

Sanofi and Regeneron Pharmaceuticals have announced a significant advancement in dermatological care with the U.S. Food and Drug Administration (FDA) approving Dupixent (dupilumab) for the ... Read More

FDA approves Serenity Pharmaceuticals’ Noctiva for nocturnal polyuria

pharmanewsdaily- March 5, 2017 0

Serenity Pharmaceuticals has received U.S. Food and Drug Administration (FDA) approval for Noctiva (desmopressin acetate), a nasal spray developed to treat nocturnal polyuria syndrome in ... Read More

FDA approves Lexicon Pharmaceuticals’ Xermelo for carcinoid syndrome diarrhea

pharmanewsdaily- March 1, 2017 0

Lexicon Pharmaceuticals has received approval from the US Food and Drug Administration (FDA) for its oral drug Xermelo (telotristat ethyl) 250mg, to be used in ... Read More

Slayback Pharma launches Generic Zovirax Ointment for genital herpes in US

pharmanewsdaily- December 25, 2016 0

Slayback Pharma LLC has announced the launch of its new generic treatment for genital herpes, Generic Zovirax Ointment (Acyclovir Ointment) 5%, in the United States, ... Read More

Mylan launches generic hypertension drugs Benicar and Benicar HCT in US

pharmanewsdaily- November 6, 2016 0

Global pharmaceutical giant Mylan has made a significant stride in the hypertension treatment market with the US launch of the first generic versions of Daiichi ... Read More